Related Experiment Video

Updated: Sep 26, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Targeting p53 in cancer

P Chène1

  • 1Novartis, Oncology Department, Basel CH-4002, Switzerland. patrick_chene@yahoo.com

Current Medicinal Chemistry. Anti-Cancer Agents
|April 8, 2003
PubMed

Insights

Loss of p53 function accelerates cancer development and impacts treatment efficacy. Research focuses on targeting altered p53 pathways using biological and chemical strategies to improve cancer therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Drug Discovery

Background:

  • Loss of p53 function is a critical event in cancer development.
  • Altered p53 influences the effectiveness of chemotherapy and radiotherapy.
  • The p53 pathway is a key target for anti-cancer drug development.

Purpose of the Study:

  • To review current progress in strategies targeting tumors with altered p53.
  • To analyze biological and chemical approaches for p53-targeted cancer therapy.

Main Methods:

  • Review of current academic and industrial research on p53.
  • Categorization of strategies into biological and chemical approaches.
  • Analysis of specific therapeutic tactics within each strategy.

Main Results:

  • Biological strategies involve immunotherapy, gene therapy, and oncolytic viruses.
  • Chemical strategies focus on stabilizing/activating p53 mutants, inhibiting p53-hdm2 interactions, or targeting chaperones.
  • Diverse approaches are under investigation to exploit p53 alterations in cancer.

Conclusions:

  • Targeting the p53 pathway offers promising avenues for novel cancer treatments.
  • Both biological and chemical strategies present distinct but potentially synergistic therapeutic opportunities.
  • Continued research is essential to translate these strategies into effective clinical applications.

More Related Videos

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Purification of Ubiquitinated p53 Proteins from Mammalian Cells10:55

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...